Literature DB >> 17937441

Genotype/phenotype correlations in two patients with 12q subtelomere deletions.

Dmitriy M Niyazov1, Zafar Nawaz, April N Justice, Helga V Toriello, Christa Lese Martin, Margaret P Adam.   

Abstract

Subtelomeric imbalances have been implicated in developmental delay and mental retardation (MR) and described for most chromosomes. This study reports the first detailed description of two individuals with de novo 12q subtelomere deletions and high-resolution mapping of their deletion size with oligonucleotide array CGH for genotype/phenotype comparisons. Patient 1 is an 8-year-old male with borderline mild MR, food-seeking behavior, obesity, no significant dysmorphic facial features, abnormal hair whorl pattern, brachydactyly and mild clinodactyly. Patient 2 is a 12-year-old male with mild MR, food-seeking behavior, obesity, short stature, mild dysmorphic facial features, multicystic kidney and unilateral cryptorchidism. Both patients share a deleted region of approximately 1.6 Mb, including 14 known genes, which perhaps contributed to their similar phenotypes. However, Patient 2 has more severe MR and organ system involvement, possibly due to the larger deletion size ( approximately 4.5 Mb) including an additional eight genes, although it is difficult to make phenotype/genotype correlations based on only two patients. Due to the relatively mild presentation of both of our patients, we propose that a proportion of individuals with subtelomeric imbalances may go undetected and therefore, recommend subtelomeric studies be carried out for cases of unexplained mild MR or isolated learning disability (LD) with behavioral problems in the absence of major dysmorphic features or birth defects. In addition, 12q subtelomeric deletions should be considered in the differential diagnosis of patients presenting with food-seeking behavior and resultant obesity, as well as those referred to rule out Prader-Willi syndrome. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17937441     DOI: 10.1002/ajmg.a.32005

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Pivotal role of the muscle-contraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies.

Authors:  Carlo V Cannistraci; Jernej Ogorevc; Minja Zorc; Timothy Ravasi; Peter Dovc; Tanja Kunej
Journal:  BMC Med Genomics       Date:  2013-02-14       Impact factor: 3.063

2.  Chromosome 12q24.31-q24.33 deletion causes multiple dysmorphic features and developmental delay: First mosaic patient and overview of the phenotype related to 12q24qter defects.

Authors:  Jawaher Al-Zahrani; Naji Al-Dosari; Nada Abudheim; Tarfa A Alshidi; Dilek Colak; Ola Al-Habit; Ali Al-Odaib; Nadia Sakati; Brian Meyer; Pinar T Ozand; Namik Kaya
Journal:  Mol Cytogenet       Date:  2011-04-02       Impact factor: 2.009

3.  Structural Chromosome Abnormalities Associated with Obesity: Report of Four New subjects and Review of Literature.

Authors:  Majed J Dasouki; Erin L Youngs; Karine Hovanes
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

4.  Investigation of selected genomic deletions and duplications in a cohort of 338 patients presenting with syndromic obesity by multiplex ligation-dependent probe amplification using synthetic probes.

Authors:  Carla S D'Angelo; Monica C Varela; Cláudia Ie de Castro; Chong A Kim; Débora R Bertola; Charles M Lourenço; Ana Beatriz A Perez; Celia P Koiffmann
Journal:  Mol Cytogenet       Date:  2014-10-31       Impact factor: 2.009

Review 5.  Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.

Authors:  Chong Kun Cheon
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-09-30

6.  Autism associated with 12q (12q24.31-q24.33) deletion: further report of an exceedingly rare disorder.

Authors:  Jaime Lin; Gigliolle Romancini de Souza-Lin; Fernanda Coan Antunes; Letícia Burato Wessler; Emílio Luiz Streck; Cinara Ludvig Gonçalves
Journal:  Einstein (Sao Paulo)       Date:  2020-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.